Skip to content
TrialX Logo
  • Home
  • Categories
    • Patient Recruitment
    • Clinical Trial Awareness
    • Remote Data Collection
    • Patient Engagement
    • Product Release
  • Solutions
    • iConnect – Patient Recruitment Management
    • xPAND – Remote Data Collection
    • CureTalks – Raise Awareness
  • Resources
    • Blogs
    • Press
    • Webinars
  • About Us
    • Team
    • Careers
  • Contact Us
  • Patient Recruitment
  • Clinical Trial Awareness
  • Remote Data Collection
  • Patient Engagement
  • Product Release

Tag: Cancer treatment

November 14th, 2017 • •
Clinical Trials, CureTalks, Drugs, New Treatments

CAR-T Cell Therapy Clinical Trials – Promising Advancement in Medicine

Two radically new gene based immunotherapies were approved by the FDA this year – Kymriah followed  by Yescarta – in August and October, respectively. Approved in August 2017, before Novartis named the drug Kymriah (Tisagenlecleucel) – it…

Shweta Mishra
Shweta Mishra
♥22

About TrialX

TrialX is a clinical research and space health informatics company headquartered in New York City. From launching the first clinical trials app on Google Health in 2008, to powering online patient recruitment and research data collection for space missions, TrialX is empowering clinical research here on earth and beyond.

Subscribe

About

TrialX is a clinical research and space health informatics company headquartered in New York City. From launching the first clinical trials app on Google Health in 2008, to powering online patient recruitment and research data collection for space missions, TrialX is empowering clinical research here on earth and beyond.

Latest Posts

  • February 23rd, 2023

    What’s in scope for future clinical trials? Learnings from the #SCOPEsummit

  • February 20th, 2023

    TrialX iConnect DEI Toolkit Tackles Diversity Challenges in Clinical Trial Recruitment

  • February 1st, 2023

    Match, Connect and Engage Better with New Patient Recruitment Tools in TrialX iConnect

  • December 22nd, 2022

    TrialX Year-In-Review-2022

Follow Us

    Copyright 2023 TrialX. All Rights Reserved.